In addition, 29.4% of known Cav1 interaction partners were downregulated, verifying the dysfunction of CAV1. Cav1 mutations carriers seem to cause a phenotypic spectra ranging from no symptoms to pulmonary hypertension, partial lipodystrophy and a severe progeroid syndrome. Here, CAV1 is linked to progeroid syndrome.